ESPN 50th Annual Meeting

ESPN 2017


 
PREVENTION OF RELAPSE OF UTI IN CHILDREN
IGOR ZORIN Albina Vyalkova Lyubov Gordienko Svetlana Plotnikova Svetlana Tchesnokova

1- Orenburg medical university
 
Introduction:

 The aim of the study was to evaluate the effectiveness of antirelapse therapy of UTI in children. 

Material and methods:

We examined 236 children aged from 1 year to 17 years with UTI. Patients underwent DMSA scan and US examination, microbiological investigations of urine, renal function on the sample Rehberg translated at the Schwartz formula. Examined patients were divided in 2 groups:

I – children who received Canephron N (n=117);

II – children who didn’t receive Canephron N (n=119).

 Definition of indicators was carried out in dynamics of 1 year from the start of antirelapse therapy of UTI with antimicrobial and fitodrag Canephron N. The dose was adjusted to patients individually depending on age, weight of the child. 

 

Results:

 The main performance indicators of antirelapse therapy of UTI with antimicrobial and fitodrag Canephron N was decrease on 27 % (р<0,05) frequency and duration of UTI in patients who received Canephron N (n=117). 

Conclusions:

 Antirelapse therapy of UTI with antimicrobial and fitodrag Canephron N as a measure of prevention of progression of UTI is effective.  Evaluating the effectiveness of antirelapse therapy of UTI with antimicrobial and fitodrag Canephron N justifies the use of these groups of drugs as prevention of progression of UTI in children.